Figure 2a: Treatment response throughout the study – itt. Treatment response from baseline is shown as proportion of subjects with HIV-1 RNA <50 copies/mL (light gray), 50-400 copies/mL (diagonal stripes) or >400 copies/mL (dotted). Subjects excluded at week 24 (dark grey) as per study design, drop-outs for other reasons (black) and missing values (white) are also shown for each time point. ITT, Intention-to-treat analysis; LPV/r, Lopinavir/ ritonavir; NRTI, Nucleoside Reverse Transcriptase Inhibitor; TDF, Tenofovir Disoproxyl Fumarate; BL, Baseline; W, treatment week.